位置:首页 > 蛋白库 > KDGK2_HALVD
KDGK2_HALVD
ID   KDGK2_HALVD             Reviewed;         318 AA.
AC   D4GR05; L9V354;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 1.
DT   03-AUG-2022, entry version 65.
DE   RecName: Full=2-dehydro-3-deoxygalactonokinase {ECO:0000305};
DE            EC=2.7.1.58 {ECO:0000269|PubMed:25287957};
DE   AltName: Full=2-keto-3-deoxygalactonate kinase {ECO:0000303|PubMed:25287957};
DE            Short=KDGal kinase {ECO:0000303|PubMed:25287957};
DE   AltName: Full=KDGK-2 {ECO:0000303|PubMed:25287957};
GN   Name=kdgK2 {ECO:0000303|PubMed:25287957};
GN   OrderedLocusNames=HVO_A0328 {ECO:0000312|EMBL:ADE02032.1};
OS   Haloferax volcanii (strain ATCC 29605 / DSM 3757 / JCM 8879 / NBRC 14742 /
OS   NCIMB 2012 / VKM B-1768 / DS2) (Halobacterium volcanii).
OG   Plasmid pHV4.
OC   Archaea; Euryarchaeota; Stenosarchaea group; Halobacteria; Haloferacales;
OC   Haloferacaceae; Haloferax.
OX   NCBI_TaxID=309800;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 29605 / DSM 3757 / JCM 8879 / NBRC 14742 / NCIMB 2012 / VKM
RC   B-1768 / DS2;
RX   PubMed=20333302; DOI=10.1371/journal.pone.0009605;
RA   Hartman A.L., Norais C., Badger J.H., Delmas S., Haldenby S., Madupu R.,
RA   Robinson J., Khouri H., Ren Q., Lowe T.M., Maupin-Furlow J.,
RA   Pohlschroder M., Daniels C., Pfeiffer F., Allers T., Eisen J.A.;
RT   "The complete genome sequence of Haloferax volcanii DS2, a model
RT   archaeon.";
RL   PLoS ONE 5:E9605-E9605(2010).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT,
RP   INDUCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=DS2 / DS70 / H26;
RX   PubMed=25287957; DOI=10.1111/1574-6968.12617;
RA   Pickl A., Johnsen U., Archer R.M., Schoenheit P.;
RT   "Identification and characterization of 2-keto-3-deoxygluconate kinase and
RT   2-keto-3-deoxygalactonate kinase in the haloarchaeon Haloferax volcanii.";
RL   FEMS Microbiol. Lett. 361:76-83(2014).
CC   -!- FUNCTION: Involved in galactose catabolism. Catalyzes the
CC       phosphorylation of 2-keto-3-deoxygalactonate (KDGal) to produce 2-keto-
CC       3-deoxy-6-phosphogalactonate (KDPGal). Can also phosphorylate 2-keto-3-
CC       deoxygluconate (KDG) to 2-keto-3-deoxy-6-phosphogluconate (KDPG), but
CC       the catalytic efficiency for KDGal is 50-fold higher than for KDG.
CC       {ECO:0000269|PubMed:25287957}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-dehydro-3-deoxy-D-galactonate + ATP = 2-dehydro-3-deoxy-6-
CC         phospho-D-galactonate + ADP + H(+); Xref=Rhea:RHEA:16525,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:57989,
CC         ChEBI:CHEBI:58298, ChEBI:CHEBI:456216; EC=2.7.1.58;
CC         Evidence={ECO:0000269|PubMed:25287957};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16526;
CC         Evidence={ECO:0000269|PubMed:25287957};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.2 mM for KDGal {ECO:0000269|PubMed:25287957};
CC         KM=8.8 mM for KDG {ECO:0000269|PubMed:25287957};
CC         KM=0.3 mM for ATP {ECO:0000269|PubMed:25287957};
CC         Vmax=148 umol/min/mg enzyme with KDGal as substrate
CC         {ECO:0000269|PubMed:25287957};
CC         Vmax=125 umol/min/mg enzyme with KDG as substrate
CC         {ECO:0000269|PubMed:25287957};
CC   -!- SUBUNIT: Homohexamer. {ECO:0000269|PubMed:25287957}.
CC   -!- INDUCTION: Highly induced by galactose. {ECO:0000269|PubMed:25287957}.
CC   -!- DISRUPTION PHENOTYPE: Deletion of the gene does not affect growth on
CC       glucose or galactose. Double deletion mutant kdgK1/kdgK2 loses the
CC       ability to grow on galactose. {ECO:0000269|PubMed:25287957}.
CC   -!- SIMILARITY: Belongs to the carbohydrate kinase PfkB family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP001955; ADE02032.1; -; Genomic_DNA.
DR   RefSeq; WP_004043241.1; NZ_AOHU01000058.1.
DR   AlphaFoldDB; D4GR05; -.
DR   SMR; D4GR05; -.
DR   STRING; 309800.C498_10271; -.
DR   EnsemblBacteria; ADE02032; ADE02032; HVO_A0328.
DR   GeneID; 8923588; -.
DR   KEGG; hvo:HVO_A0328; -.
DR   PATRIC; fig|309800.29.peg.1997; -.
DR   eggNOG; arCOG00014; Archaea.
DR   HOGENOM; CLU_027634_0_1_2; -.
DR   OMA; CIGIEPL; -.
DR   OrthoDB; 36944at2157; -.
DR   BRENDA; 2.7.1.11; 2561.
DR   BRENDA; 2.7.1.178; 2561.
DR   BRENDA; 2.7.1.58; 2561.
DR   Proteomes; UP000008243; Plasmid pHV4.
DR   GO; GO:0008671; F:2-dehydro-3-deoxygalactonokinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.1190.20; -; 1.
DR   InterPro; IPR011611; PfkB_dom.
DR   InterPro; IPR029056; Ribokinase-like.
DR   Pfam; PF00294; PfkB; 1.
DR   SUPFAM; SSF53613; SSF53613; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Carbohydrate metabolism; Kinase; Nucleotide-binding; Plasmid;
KW   Reference proteome; Transferase.
FT   CHAIN           1..318
FT                   /note="2-dehydro-3-deoxygalactonokinase"
FT                   /id="PRO_0000449270"
FT   ACT_SITE        260
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:Q97U29"
FT   BINDING         35..39
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q97U29"
FT   BINDING         90
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q97U29"
FT   BINDING         105..107
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q97U29"
FT   BINDING         167..169
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q97U29"
FT   BINDING         169
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q97U29"
FT   BINDING         228..233
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q97U29"
FT   BINDING         257..260
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q97U29"
FT   BINDING         260
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q97U29"
FT   BINDING         296
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q97U29"
SQ   SEQUENCE   318 AA;  33998 MW;  98998ACAD21E1BA2 CRC64;
     MTAELVTFGE TMIRLSPPEG ERIETARSLE FRTAGAESNV AVAASRLGCS AAWLSKLPDS
     PLGRRVTTEL RTHGVEPYVR WDDDARQGAY YIEQGRAPRP TNVIYDRADA AVTTARPDEL
     AVDIVEDAAA FYTSGITPAL SETLRETTGE LLQTATEAGT TTAFDLNYRS KLWSPSDARD
     ACESLFPKVD VLVAAERDIR AVLELDGDAP TLASELAGDF DFETVVVTRG EDGALARHGG
     TVYEQPVFET DTVDAIGTGD AFVGAFLSRL IAGEPVETAL AYGAATAALK RTVHGDLAVV
     TPDEVERVLR GGDAGIDR
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024